Pharmacokinetics of ftorafur after intravenous and oral administration Markku I. AnttilaEero A. SotaniemiHannu T. Sundquist Original Articles Pages: 150 - 153
VP16-213 and cyclophosphamide in advanced breast cancer J. EstapéL. CireraF. Doncel Original Articles Pages: 154 - 157
Trilostane in the treatment of advanced breast cancer C. G. BeardwellA. C. Hindleyd. Bu'Lock Original Articles Pages: 158 - 160
Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay Matti S. AaproDavid S. AlbertsSydney E. Salmon Original Articles Pages: 161 - 166
Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice Gianni SavaTullio Giraldi Original Articles Pages: 167 - 169
Determination of the antitumor agent SOAz (1,3,3,5,5 Pentakis(Aciridino)-1λ6,2,4,6,3λ5,5λ5 Thia-Triazadiphosphorine-1-Oxide) by a gas chromatographic assay suitable for pharmacokinetic studies in man Maria H. Beneken genaamd KolmerSjoerd RodenhuisDonald R. A. Uges Original Articles Pages: 170 - 173
Clinical pharmacokinetics of (NPAz2)2NSOAz: ‘SOAz’ Sjoerd RodenhuisArnold H. J. ScafJohan C. van de Grampel Original Articles Pages: 174 - 177
Phase i clinical trial of (NPAz2)2NSOAz: ‘SOAz’ Sjoerd RodenhuisNanno H. MulderJohan C. van de Grampel Original Articles Pages: 178 - 181
Antitumor efficacy of seventeen anticancer drugs in human breast cancer xenograft (MX-1) transplanted in nude mice Katsuhiro InoueShuichi FujimotoMakoto Ogawa Original Articles Pages: 182 - 186
A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography W. BolanowskaT. GessnerH. Preisler Original Articles Pages: 187 - 191
Decreased plasma half-life of cyclophosphamide during repeated high-dose administration M. I. GrahamI. C. ShawA. E. M. McLean Original Articles Pages: 192 - 193
Danazol treatment for advanced breast cancer R. Charles CoombesDavid PerezTrevor J. Powles Original Articles Pages: 194 - 195
Brain, CSF, and tumor pharmacokinetics of α-difluoromethylornithine in rats and dogs Victor A. LevinJudit CsejteyDeborah J. Byrd Original Articles Pages: 196 - 199
Clinical pharmacology of the anticancer polypeptide neocarzinostatin Stephen W. HallJames KnightEugene McKelvey Original Articles Pages: 200 - 204
High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus Robert L. SouhamiPeter G. HarperJohn D. M. Richards Original Articles Pages: 205 - 207
Flow-cytometric analysis of DNA distribution after VP16-213 treatment of Lewis lung carcinoma E. ErbaP. UbezioL. Morasca Original Articles Pages: 208 - 211
Pharmacokinetics of melphalan in children following high-dose intravenous injection I. A.-K. TahaR. A. AhmadH. J. Rogers Original Articles Pages: 212 - 216
Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model Don V. Jackson JrMichael L. BarringerManford C. Castle Original Articles Pages: 217 - 220
Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL) Abdallah S. AwidiMusleh S. TarawnehSamir S. Amr Short Communication Pages: 221 - 222
Reversible microangiopathic hemolytic anemia after mitomycin C David J. Perry Short Communication Pages: 223 - 223
Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse Guy GarayJörge MiloneMariana Eppinger-Helft Short Communication Pages: 224 - 226
Copper levels and the adriamycin inhibition of proliferating cells Bhanu Lyengar Letter to the Editor Pages: 227 - 227
Adjuvant oral Razoxane (ICRF 159) in resectable colo-rectal cancer M. L. SlevinV. J. HarveyC. Wastell Letter to the Editor Pages: 228 - 229
